# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-24-112054
Filing Date
2024-10-29
Accepted
2024-10-29 08:09:13
Documents
49
Period of Report
2024-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2427013d1_8k.htm iXBRL | 8-K | 78311
2 | EXHIBIT 2.1 | tm2427013d1_ex2-1.htm | EX-2.1 | 733397
3 | EXHIBIT 3.1 | tm2427013d1_ex3-1.htm | EX-3.1 | 83903
4 | EXHIBIT 10.1 | tm2427013d1_ex10-1.htm | EX-10.1 | 60936
5 | EXHIBIT 10.2 | tm2427013d1_ex10-2.htm | EX-10.2 | 59408
6 | EXHIBIT 10.3 | tm2427013d1_ex10-3.htm | EX-10.3 | 294052
7 | EXHIBIT 10.4 | tm2427013d1_ex10-4.htm | EX-10.4 | 122683
8 | EXHIBIT 10.5 | tm2427013d1_ex10-5.htm | EX-10.5 | 36040
9 | EXHIBIT 99.1 | tm2427013d1_ex99-1.htm | EX-99.1 | 7186
10 | EXHIBIT 99.2 | tm2427013d1_ex99-2.htm | EX-99.2 | 30207
11 | EXHIBIT 99.3 | tm2427013d1_ex99-3.htm | EX-99.3 | 38563
12 | EXHIBIT 99.4 | tm2427013d1_ex99-4.htm | EX-99.4 | 26524
16 | GRAPHIC | tm2427013d1_ex99-1img001.jpg | GRAPHIC | 16872
17 | GRAPHIC | tm2427013d1_ex99-1img002.jpg | GRAPHIC | 4762
18 | GRAPHIC | tm2427013d1_ex99-3img001.jpg | GRAPHIC | 90711
19 | GRAPHIC | tm2427013d1_ex99-3img002.jpg | GRAPHIC | 363712
20 | GRAPHIC | tm2427013d1_ex99-3img003.jpg | GRAPHIC | 198062
21 | GRAPHIC | tm2427013d1_ex99-3img004.jpg | GRAPHIC | 218872
22 | GRAPHIC | tm2427013d1_ex99-3img005.jpg | GRAPHIC | 226564
23 | GRAPHIC | tm2427013d1_ex99-3img006.jpg | GRAPHIC | 283162
24 | GRAPHIC | tm2427013d1_ex99-3img007.jpg | GRAPHIC | 62709
25 | GRAPHIC | tm2427013d1_ex99-3img008.jpg | GRAPHIC | 261857
26 | GRAPHIC | tm2427013d1_ex99-3img009.jpg | GRAPHIC | 218679
27 | GRAPHIC | tm2427013d1_ex99-3img010.jpg | GRAPHIC | 196332
28 | GRAPHIC | tm2427013d1_ex99-3img011.jpg | GRAPHIC | 253302
29 | GRAPHIC | tm2427013d1_ex99-3img012.jpg | GRAPHIC | 238086
30 | GRAPHIC | tm2427013d1_ex99-3img013.jpg | GRAPHIC | 326849
31 | GRAPHIC | tm2427013d1_ex99-3img014.jpg | GRAPHIC | 186211
32 | GRAPHIC | tm2427013d1_ex99-3img015.jpg | GRAPHIC | 242097
33 | GRAPHIC | tm2427013d1_ex99-3img016.jpg | GRAPHIC | 228106
34 | GRAPHIC | tm2427013d1_ex99-3img017.jpg | GRAPHIC | 69901
35 | GRAPHIC | tm2427013d1_ex99-3img018.jpg | GRAPHIC | 271720
36 | GRAPHIC | tm2427013d1_ex99-3img019.jpg | GRAPHIC | 50502
37 | GRAPHIC | tm2427013d1_ex99-3img020.jpg | GRAPHIC | 196706
38 | GRAPHIC | tm2427013d1_ex99-3img021.jpg | GRAPHIC | 183912
39 | GRAPHIC | tm2427013d1_ex99-3img022.jpg | GRAPHIC | 130290
40 | GRAPHIC | tm2427013d1_ex99-3img023.jpg | GRAPHIC | 74734
| Complete submission text file | 0001104659-24-112054.txt |  | 8432112

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL TAXONOMY EXTENSION SCHEMA | glyc-20241028.xsd | EX-101.SCH | 3030
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | glyc-20241028_lab.xml | EX-101.LAB | 34240
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | glyc-20241028_pre.xml | EX-101.PRE | 22369
51 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2427013d1_8k_htm.xml | XML | 3555

Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 241402744
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)